Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March–December 2021
Pandemic
DOI:
10.1371/journal.pone.0307805
Publication Date:
2024-09-06T17:35:22Z
AUTHORS (12)
ABSTRACT
Background Healthcare workers (HCWs) have suffered considerable morbidity and mortality during the COVID-19 pandemic. Few data on vaccine effectiveness (VE) are available from middle-income countries in WHO European Region. We evaluated primary series VE against laboratory-confirmed among HCWs Georgia. Methods six hospitals Georgia were invited to enroll a prospective cohort study conducted March 19–December 5, 2021. Participants completed weekly symptom questionnaires. Symptomatic tested by RT-PCR and/or rapid antigen test (RAT), participants routinely for SARS-CoV-2 or RAT, regardless of symptoms. Serology was collected at enrolment, quarterly thereafter, electrochemiluminescence immunoassay antibodies. defined vaccination as two doses received ≥14 days before onset. estimated (1-hazard ratio)*100 using Cox proportional hazards model with status time-varying covariate. Estimates adjusted potential confounders that changed estimate more than 5%, according change-in-estimate approach. Results Overall, 1561/3849 (41%) eligible enrolled included analysis. The median age 40 (IQR: 30–53), 1318 (84%) female, 1003 (64%) had laboratory evidence prior SARS-Cov-2 infection. At 1300 (83%) unvaccinated; By end, 1082 (62%) (69% BNT162b2 (Pfizer-BioNTech); 22% BBIBP-CorV (Sinopharm); 9% other). During period, 191(12%) new PCR- RAT-confirmed symptomatic RAT- confirmed infection 58% (95%CI: 41; 70) all vaccinations, 68% 51; 79) BNT162b2, 40% 1; 64) vaccines. Among previously infected HCWs, 11; 80). medically attended 52% 28; 68), hospitalization 69% (95% CI: 36; 85). period predominant Delta variant circulation (July-December 2021), 30; 66). Conclusions Primary effective preventing most whom previous infection, mainly circulation. Our results support utility series, importance increasing coverage, even individuals.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....